𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Psoriatic arthritis and chronic lymphoedema: treatment efficacy by adalimumab

✍ Scribed by Denise Tong; Sharron Eather; Nicholas Manolios

Publisher
Springer
Year
2009
Tongue
English
Weight
53 KB
Volume
28
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adalimumab for long-term treatment of ps
Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial
✍ Dafna D. Gladman; Philip J. Mease; Christopher T. Ritchlin; Ernest H. S. Choy; J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 281 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and safety of treatment with adalimumab, a fully human anti–tumor necrosis factor (anti‐TNF) monoclonal antibody, over 48 weeks in patients with moderate to severe psoriatic arthritis (PsA). ## Methods Patients who completed the Adalimumab Effect

Efficacy and safety of leflunomide in th
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial
✍ J. Peter Kaltwasser; Peter Nash; Dafna Gladman; Cheryl F. Rosen; Frank Behrens; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 2 views

## Abstract ## Objective Current treatment options for psoriatic arthritis (PsA) are limited. Leflunomide, an oral pyrimidine synthesis inhibitor, is highly effective in the treatment of rheumatoid arthritis, and small studies have suggested similar efficacy in PsA. We undertook this double‐blind,